Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia 1Hodgkin Disease 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Radiotherapy 22Fluorouracil 20Oxaliplatin 19Leucovorin 14Cisplatin 14Paclitaxel 10Radiation 8Irinotecan 8Docetaxel 7Capecitabine 7Cetuximab 6Carboplatin 6pembrolizumab 5Neoadjuvant Therapy 5Trastuzumab 4Taxes 4Chemotherapy, Adjuvant 4Panitumumab 3Microarray Analysis 3Immunohistochemistry 3Folfox protocol 3Epirubicin 3Biopsy 3tucatinib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Magnetic Resonance Spectroscopy 2Gene Expression Profiling 2Gefitinib 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma Of Esophagus × pegylated granulocyte colony-stimulating factor, human × Clear all
NCT00069953 2017-02-17

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Radiation Therapy Oncology Group

Phase 2 Completed
43 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡